{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:06:02Z","timestamp":1790712362413,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Carrying the apolipoprotein E (ApoE) \u01904 allele is associated with an increased risk of cerebral amyloidosis and late-onset Alzheimer\u2019s disease, but the degree to which apoE glycosylation affects its development is not clear. In a previous pilot study, we identified distinct total and secondary isoform-specific cerebral spinal fluid (CSF) apoE glycosylation profiles, with the E4 isoform having the lowest glycosylation percentage (E2\u2009&gt;\u2009E3\u2009&gt;\u2009E4). In this work, we extend the analysis to a larger cohort of individuals (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009106), utilizing matched plasma and CSF samples with clinical measures of AD biomarkers. The results confirm the isoform-specific glycosylation of apoE in CSF, resulting from secondary CSF apoE glycosylation patterns. CSF apoE glycosylation percentages positively correlated with CSF A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    levels (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.53,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). These correlations were not observed for plasma apoE glycosylation. CSF total and secondary apoE glycosylation percentages also correlated with the concentration of CSF small high-density lipoprotein particles (s-HDL-P), which we have previously shown to be correlated with CSF A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    levels and measures of cognitive function. Desialylation of apoE purified from CSF showed reduced A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    degradation in microglia with E4\u2009&gt;\u2009E3 and increased binding affinity to heparin. These results indicate that apoE glycosylation has a new and important role in influencing brain A\u03b2 metabolism and can be a potential target of treatment.\n                  <\/jats:p>","DOI":"10.1186\/s13195-023-01239-0","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:02:22Z","timestamp":1684810942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 allele"],"prefix":"10.1186","volume":"15","author":[{"given":"Cristiana J.","family":"Meuret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Smadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaila Ann","family":"Bantugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald M.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Lan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobrin","family":"Nedelkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein N.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"issue":"3","key":"1239_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1471-4159.2000.0741008.x","volume":"74","author":"M Michikawa","year":"2000","unstructured":"Michikawa M, et al. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture. J Neurochem. 2000;74(3):1008\u201316.","journal-title":"J Neurochem"},{"issue":"89","key":"1239_CR2","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci Transl Med. 2011;3(89):89ra57-89ra57.","journal-title":"Sci Transl Med"},{"issue":"9","key":"1239_CR3","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC. Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life. 2014;66(9):616\u201323.","journal-title":"IUBMB Life"},{"issue":"1","key":"1239_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0896-6273(95)90079-9","volume":"15","author":"J N\u00e4slund","year":"1995","unstructured":"N\u00e4slund J, et al. Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer\u2019s disease brain. Neuron. 1995;15(1):219\u201328.","journal-title":"Neuron"},{"issue":"Pt 2","key":"1239_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/bj3480359","volume":"348 Pt 2","author":"T Tokuda","year":"2000","unstructured":"Tokuda T, et al. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid beta peptides. Biochem J. 2000;348 Pt 2(Pt 2):359\u201365.","journal-title":"Biochem J"},{"issue":"8","key":"1239_CR6","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.M500114-JLR200","volume":"46","author":"J Ruiz","year":"2005","unstructured":"Ruiz J, et al. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res. 2005;46(8):1721\u201331.","journal-title":"J Lipid Res"},{"issue":"51","key":"1239_CR7","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1021\/bi1017655","volume":"49","author":"D Nguyen","year":"2010","unstructured":"Nguyen D, et al. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry. 2010;49(51):10881\u20139.","journal-title":"Biochemistry"},{"issue":"2","key":"1239_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.12649","volume":"19","author":"AE Martinez","year":"2023","unstructured":"Martinez AE, Weissberger G, Kuklenyik Z, He X, Meuret C, Parekh T, et al. The small HDL particle hypothesis of Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(2):391\u2013404. https:\/\/doi.org\/10.1002\/alz.12649.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1239_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/glycob\/cwz084","volume":"30","author":"SA Flowers","year":"2020","unstructured":"Flowers SA, et al. O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain. Glycobiology. 2020;30(2):74\u201385.","journal-title":"Glycobiology"},{"issue":"6","key":"1239_CR10","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/j.1471-4159.2010.06586.x","volume":"112","author":"CC Chua","year":"2010","unstructured":"Chua CC, Lim ML, Wong BS. Altered apolipoprotein E glycosylation is associated with Abeta(42) accumulation in an animal model of Niemann-Pick Type C disease. J Neurochem. 2010;112(6):1619\u201326.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"1239_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cca.2007.10.024","volume":"388","author":"M Sugano","year":"2008","unstructured":"Sugano M, et al. Sialic acid moiety of apolipoprotein E3 at Thr(194) affects its interaction with beta-amyloid(1\u201342) peptides. Clin Chim Acta. 2008;388(1\u20132):123\u20139.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1239_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","volume":"96","author":"M Kockx","year":"2018","unstructured":"Kockx M, Traini M, Kritharides L. Cell-specific production, secretion, and function of apolipoprotein E. J Mol Med (Berl). 2018;96(5):361\u201371.","journal-title":"J Mol Med (Berl)"},{"issue":"15","key":"1239_CR13","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1016\/S0021-9258(18)81907-X","volume":"264","author":"ME Wernette-Hammond","year":"1989","unstructured":"Wernette-Hammond ME, et al. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. J Biol Chem. 1989;264(15):9094\u2013101.","journal-title":"J Biol Chem"},{"issue":"9","key":"1239_CR14","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1074\/mcp.M900430-MCP200","volume":"9","author":"Y Lee","year":"2010","unstructured":"Lee Y, et al. Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290. Mol Cell Proteomics. 2010;9(9):1968\u201381.","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"1239_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nmeth.1392","volume":"6","author":"J Nilsson","year":"2009","unstructured":"Nilsson J, et al. Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods. 2009;6(11):809\u201311.","journal-title":"Nat Methods"},{"issue":"2","key":"1239_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/pr300963h","volume":"12","author":"A Halim","year":"2013","unstructured":"Halim A, et al. LC-MS\/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins. J Proteome Res. 2013;12(2):573\u201384.","journal-title":"J Proteome Res"},{"issue":"11","key":"1239_CR17","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1021\/acs.jproteome.9b00450","volume":"18","author":"C Zhu","year":"2019","unstructured":"Zhu C, et al. Site-specific glycoprofiles of HDL-associated ApoE are correlated with HDL functional capacity and unaffected by short-term diet. J Proteome Res. 2019;18(11):3977\u201384.","journal-title":"J Proteome Res"},{"issue":"1","key":"1239_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","volume":"917","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, et al. Astrocytes synthesize apolipoprotein-E and metabolize apolipoprotein E-containing lipoproteins. Biochem Biophys Acta. 1987;917(1):148\u201361.","journal-title":"Biochem Biophys Acta"},{"issue":"9","key":"1239_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/S0026-0495(99)90136-1","volume":"48","author":"P Marmillot","year":"1999","unstructured":"Marmillot P, et al. Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver. Metabolism-Clinical and Experimental. 1999;48(9):1184\u201392.","journal-title":"Metabolism-Clinical and Experimental"},{"key":"1239_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13578-016-0079-5","volume":"6","author":"Y Itakura","year":"2016","unstructured":"Itakura Y, et al. N- and O-glycan cell surface protein modifications associated with cellular senescence and human aging. Cell Biosci. 2016;6:14.","journal-title":"Cell Biosci"},{"issue":"1","key":"1239_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0197-4580(94)90149-X","volume":"15","author":"TM Maguire","year":"1994","unstructured":"Maguire TM, et al. A decrease in serum sialyltransferase levels in Alzheimer\u2019s disease. Neurobiol Aging. 1994;15(1):99\u2013102.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"1239_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3233\/JAD-200203","volume":"76","author":"Y Hu","year":"2020","unstructured":"Hu Y, et al. Simple and fast assay for apolipoprotein E phenotyping and glycotyping: discovering isoform-specific glycosylation in plasma and cerebrospinal fluid. J Alzheimers Dis. 2020;76(3):883\u201393.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1239_CR23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1046\/j.1365-2273.2000.00422-17.x","volume":"25","author":"SB Nair","year":"2000","unstructured":"Nair SB, et al. Fibroblast growth factor receptor expression investibular schwannoma. Clin Otolaryngol Allied Sci. 2000;25(6):570\u20136.","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"8","key":"1239_CR24","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1373\/clinchem.2007.100586","volume":"54","author":"MP Caulfield","year":"2008","unstructured":"Caulfield MP, et al. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem. 2008;54(8):1307\u201316.","journal-title":"Clin Chem"},{"issue":"28","key":"1239_CR25","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"QL Ma","year":"2009","unstructured":"Ma QL, et al. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci. 2009;29(28):9078\u201389.","journal-title":"J Neurosci"},{"issue":"Suppl","key":"1239_CR26","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","volume":"50","author":"RW Mahley","year":"2009","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J Lipid Res. 2009;50(Suppl):S183\u20138.","journal-title":"J Lipid Res"},{"issue":"4","key":"1239_CR27","first-page":"185","volume":"6","author":"TM Maguire","year":"1995","unstructured":"Maguire TM, Breen KC. A decrease in neural sialyltransferase activity in Alzheimer\u2019s disease. Dementia. 1995;6(4):185\u201390.","journal-title":"Dementia"},{"issue":"9","key":"1239_CR28","doi-asserted-by":"publisher","first-page":"e1601576","DOI":"10.1126\/sciadv.1601576","volume":"3","author":"M Frenkel-Pinter","year":"2017","unstructured":"Frenkel-Pinter M, et al. Interplay between protein glycosylation pathways in Alzheimer\u2019s disease. Sci Adv. 2017;3(9):e1601576.","journal-title":"Sci Adv"},{"issue":"3\u20134","key":"1239_CR29","first-page":"171","volume":"48","author":"JD Otvos","year":"2002","unstructured":"Otvos JD. Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin Lab. 2002;48(3\u20134):171\u201380.","journal-title":"Clin Lab"},{"issue":"29","key":"1239_CR30","doi-asserted-by":"publisher","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","volume":"262","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, et al. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J Biol Chem. 1987;262(29):14352\u201360.","journal-title":"J Biol Chem"},{"issue":"3","key":"1239_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1172\/JCI112645","volume":"78","author":"R Gregg","year":"1986","unstructured":"Gregg R, et al. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Investig. 1986;78(3):815.","journal-title":"J Clin Investig"},{"issue":"8","key":"1239_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","volume":"31","author":"DM Hatters","year":"2006","unstructured":"Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolipoprotein E structure: insights into function. Trends Biochem Sci. 2006;31(8):445\u201354.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"1239_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/187152709787601867","volume":"8","author":"R Deane","year":"2009","unstructured":"Deane R, et al. Clearance of Amyloid-\u03b2 Peptide across the blood-brain barrier: implication for therapies in Alzheimers disease. CNS Neurol Disord Drug Targets. 2009;8(1):16\u201330.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"3","key":"1239_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","volume":"43","author":"R Deane","year":"2004","unstructured":"Deane R, et al. LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron. 2004;43(3):333\u201344.","journal-title":"Neuron"},{"issue":"9","key":"1239_CR35","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","volume":"93","author":"BV Zlokovic","year":"1996","unstructured":"Zlokovic BV, et al. Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci U S A. 1996;93(9):4229\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1239_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13195-022-01108-2","volume":"14","author":"MP Lennol","year":"2022","unstructured":"Lennol MP, et al. Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer\u2019s disease patients. Alzheimers Res Ther. 2022;14(1):161.","journal-title":"Alzheimers Res Ther"},{"issue":"43","key":"1239_CR37","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J Neurosci. 2012;32(43):15181\u201392.","journal-title":"J Neurosci"},{"key":"1239_CR38","doi-asserted-by":"publisher","first-page":"105631","DOI":"10.1016\/j.nbd.2022.105631","volume":"164","author":"H-J Moon","year":"2022","unstructured":"Moon H-J, Haroutunian V, Zhao L. Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-A\u03b2 interaction and A\u03b2 fibrillation. Neurobiol Dis. 2022;164:105631.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"1239_CR39","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s12031-021-01943-2","volume":"72","author":"L Song","year":"2022","unstructured":"Song L, et al. Heparan sulfate proteoglycans (HSPGs) serve as the mediator between monomeric tau and its subsequent intracellular ERK1\/2 pathway activation. J Mol Neurosci\u202f: MN. 2022;72(4):772\u201391.","journal-title":"J Mol Neurosci : MN"},{"issue":"8","key":"1239_CR40","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1016\/S0021-9258(18)68957-4","volume":"263","author":"A Lalazar","year":"1988","unstructured":"Lalazar A, et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem. 1988;263(8):3542\u20135.","journal-title":"J Biol Chem"},{"issue":"11","key":"1239_CR41","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680\u20133.","journal-title":"Nat Med"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-023-01239-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-023-01239-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:03:34Z","timestamp":1684811014000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-023-01239-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1186\/s13195-023-01239-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2003074\/v1","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the University of Southern California and all participants provided informed consent in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}